Display options
Share it on
Full text links
Wiley Free PMC Article

J Physiol. 1996 Jan 01;490:215-28. doi: 10.1113/jphysiol.1996.sp021137.

Contribution of shrinkage of extracellular space to extracellular K+ accumulation in myocardial ischaemia of the rabbit.

The Journal of physiology

G X Yan, J Chen, K A Yamada, A G Kléber, P B Corr

Affiliations

  1. Department of Internal Medicine, Washington University School of Medicine, St Louis, MO, USA.

PMID: 8745289 PMCID: PMC1158658 DOI: 10.1113/jphysiol.1996.sp021137
Free PMC Article

Abstract

1. The contribution of the concentrating effect due to shrinkage of the extracellular space (ECS) to cellular K+ efflux on extracellular potassium ([K+]o) accumulation in response to ischaemia was investigated in an isolated, blood-perfused rabbit papillary muscle preparation with a confined extracellular space. 2. The ECS was quantified using either of two extracellular markers, choline or tetramethyl ammonium (TMA), each with specific ion-selective electrodes, as well as by measurement of extracellular resistance (ro). [K+]o and [Na+]o were also measured simultaneously using K(+)- and Na(+)-selective electrodes. 3. During ischaemia, [K+]o increased 3-fold from 4.2 +/- 0.1 to 12.6 +/- 1.0 mM at 10 min (n = 10) analogous to changes in the ischaemic heart in vivo. The ECS decreased to 83.9 +/- 3.2% of control measured using 1 mM choline extracellularly (n = 9, P < 0.01) or to 85.7 +/- 0.7% of control using 1 mM TMA (n = 6, P < 0.01). Nearly identical decreases in ro (84.1 +/- 2.4%, n = 15, P < 0.01) occurred simultaneously. 4. The small decrease in the ECS contributed only 0.8-0.9 mM to the total increase in [K+]o of 8.4 mM and had a minor effect on transmembrane K+ flux. No significant differences between the relative changes in [choline] and [Na+]o were observed. This excluded a major transmembrane Na+ movement during early ischaemia. 5. Bumetanide (10 mM), an inhibitor of K(+)-Cl- cotransport, a process which is involved in cell volume regulation consequent to osmotic cell swelling, significantly attenuated the increase in [K+]o after 6 min of ischaemia (8.3 +/- 0.6 mM, n = 5 vs. 10.3 +/- 0.4 mM in the control group, n = 6, P < 0.05), whereas N-ethylmaleimide (1 mM), a stimulator of this cotransporter, augmented [K+]o accumulation (12.0 +/- 0.6 mM at 6 min, P < 0.05). 6. We conclude that during early myocardial ischaemia, a major component of [K+]o accumulation is not caused by diminution of ECS per se, but rather by increased net K+ efflux due in part to K(+)-Cl cotransport secondary to myocyte volume regulation.

Cited by

References

  1. J Physiol. 1987 Apr;385:307-24 - PubMed
  2. Circ Res. 1992 Dec;71(6):1324-33 - PubMed
  3. Neurosci Lett. 1987 Feb 24;74(2):221-6 - PubMed
  4. Am J Physiol. 1986 Aug;251(2 Pt 1):C197-208 - PubMed
  5. J Mol Cell Cardiol. 1992 Mar;24(3):323-31 - PubMed
  6. Circ Res. 1990 Jun;66(6):1461-73 - PubMed
  7. Circ Res. 1985 Dec;57(6):864-75 - PubMed
  8. Am J Physiol. 1985 Sep;249(3 Pt 1):C337-44 - PubMed
  9. Circ Res. 1991 Sep;69(3):623-37 - PubMed
  10. Am J Physiol. 1991 Jan;260(1 Pt 1):C122-31 - PubMed
  11. J Gen Physiol. 1992 Jul;100(1):89-114 - PubMed
  12. Am J Physiol. 1990 Sep;259(3 Pt 2):H962-72 - PubMed
  13. Cardiology. 1971;56(1):245-62 - PubMed
  14. J Membr Biol. 1985;88(1):1-13 - PubMed
  15. Am J Physiol. 1989 Aug;257(2 Pt 1):C159-73 - PubMed
  16. Circ Res. 1992 Aug;71(2):460-70 - PubMed
  17. J Physiol. 1981 Dec;321:225-57 - PubMed
  18. J Mol Cell Cardiol. 1988 Oct;20(10):887-96 - PubMed
  19. Circ Res. 1986 Feb;58(2):249-56 - PubMed
  20. Circ Res. 1990 Feb;66(2):478-85 - PubMed
  21. Am J Physiol. 1982 Apr;242(4):H619-28 - PubMed
  22. Circ Res. 1990 May;66(5):1255-67 - PubMed
  23. Am J Physiol. 1992 Aug;263(2 Pt 2):H333-40 - PubMed
  24. Circ Res. 1992 Feb;70(2):409-22 - PubMed
  25. Circ Res. 1990 Oct;67(4):835-43 - PubMed
  26. Circ Res. 1979 Sep;45(3):324-30 - PubMed
  27. J Physiol. 1941 Aug 11;100(1):1-63 - PubMed
  28. Circ Res. 1994 May;74(5):829-38 - PubMed
  29. Acta Physiol Scand. 1980 Apr;108(4):355-65 - PubMed
  30. Circ Res. 1981 Aug;49(2):364-81 - PubMed
  31. Science. 1954 Feb 12;119(3085):200-3 - PubMed
  32. Am J Physiol. 1977 Jan;232(1):H85-94 - PubMed
  33. Br J Pharmacol. 1990 Oct;101(2):406-10 - PubMed
  34. Am J Physiol. 1987 Nov;253(5 Pt 1):C721-30 - PubMed
  35. Annu Rev Med. 1985;36:275-84 - PubMed
  36. Circ Res. 1983 Apr;52(4):442-50 - PubMed
  37. Am J Physiol. 1993 Jun;264(6 Pt 1):C1625-30 - PubMed
  38. J Mol Cell Cardiol. 1990 Nov;22(11):1259-72 - PubMed
  39. Am J Physiol. 1974 Sep;227(3):676-83 - PubMed
  40. J Mol Cell Cardiol. 1984 May;16(5):389-94 - PubMed
  41. J Mol Cell Cardiol. 1986 Aug;18(8):769-80 - PubMed
  42. Physiol Rev. 1989 Apr;69(2):315-82 - PubMed
  43. J Physiol. 1990 Dec;431:713-41 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources